CSL Limited (CMXHF)
OTCMKTS
· Delayed Price · Currency is USD
146.50
0.00 (0.00%)
May 14, 2025, 4:00 PM EDT
CSL Limited Employees
CSL Limited had 32,698 employees as of June 30, 2024. The number of employees increased by 633 or 1.97% compared to the previous year.
Employees
32,698
Change (1Y)
633
Growth (1Y)
1.97%
Revenue / Employee
$465,778
Profits / Employee
$84,042
Market Cap
73.81B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| CytoDyn | 9 |
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 64 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
CSL Limited News
- 16 days ago - CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy - PRNewsWire
- 7 weeks ago - CSL Limited: Divergent Outlook For Its 2 Key Businesses - Seeking Alpha
- 3 months ago - CSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE) - PRNewsWire
- 3 months ago - European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine - PRNewsWire
- 3 months ago - European Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) - PRNewsWire
- 3 months ago - Half Year 2025 CSL Ltd Earnings Presentation Transcript - GuruFocus
- 3 months ago - CSL Limited 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - CSL Limited (CSLLY) Q2 2025 Earnings Call Transcript - Seeking Alpha